Module

HBV Infection: Deciding Who and When to Treat

Source: Hepatitis Annual Update 2009

HBV Infection: Deciding Who and When to Treat

Program Director: Marion G. Peters, MD, FRACP

Faculty:

Anna S. F. Lok, MD

CREDIT INFORMATION

Release Date: July 13, 2009

Expiration Date: July 12, 2010

Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Registered Nurses: 0.8 Nursing contact hours

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Identify 2 patient and/or clinical factors that serve as indications for HBV treatment deferral
Discuss patient and/or clinical factors that serve as indications for treatment initiation in HBV-infected patients
Compare and contrast finite vs long-term HBV treatment strategies

Topics covered include:

Introduction to Treatment Recommendations
Patients for Whom Therapy Is Strongly Indicated
Patients for Whom Therapy May Be Indicated
Patients for Whom Immediate Therapy Is Not Routinely Indicated
Other Considerations in Deciding When to Treat
Management Strategies—Interferon Alfa vs Nucleos(t)ide Analog Treatment
Management Strategies—De Novo Monotherapy vs Combination Therapy
Summary: Implications for Clinical Practice

Abstract

Click here to view abstract

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.